Abstract
Purpose
The purpose of this study was to assess which pain intensity dimension scale (worst, least, average, or current pain) from the Brief Pain Inventory (BPI) correlates most highly with functional interference scores in patients experiencing taxane-induced arthralgia and myalgia.
Methods
Breast cancer patients scheduled to receive docetaxel, paclitaxel, or albumin-bound paclitaxel (nab-paclitaxel) were enrolled in the study. Patients completed an initial baseline questionnaire and subsequently filled out a diary based on the BPI on days 1–7, 14, and 21 for three consecutive treatment cycles. Pain scores for worst, least, average, and current pain intensity dimensions as well as pain interference scores were recorded in the diaries and questionnaires using the BPI. Worst, least, average, and current pain scores were correlated with functional pain interference scores using Spearman’s rank correlation coefficients. A general linear mixed model of each functional interference measure was performed over time for cycles 1–3 with each pain intensity dimension scale.
Results
Among worst, average, least, and current joint pain dimensions, average joint pain scores correlated best with all BPI interference responses while average muscle pain scores correlated best with all BPI interference responses except for sleeping probability and normal work.
Conclusion
We recommend the BPI scale measuring average pain for future studies evaluating pain scores in patients experiencing taxane-induced arthralgia and myalgia.
Similar content being viewed by others
References
Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN et al (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29(11):1472–1478
Saibil S, Fitzgerald B, Freedman OC, Amir E, Napolskikh J, Salvo N et al (2010) Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey. Curr Oncol 17(4):42
Harris K, Li K, Flynn C, Chow E (2007) Worst, average or current pain in the brief pain inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases? Clin Oncol 19(7):523–527
Jensen MP (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4(1):2–21
Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J (1999) Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgia and myalgia. Gynecol Oncol 72(1):100–101
Zelman DC, Hoffman DL, Seifeldin R, Dukes EM (2003) Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis. Pain 106(1):35–42
Jensen MP (2003) Questionnaire validation: a brief guide for readers of the research literature. Clin J Pain 19(6):345–352
Jensen MP, Smith DG, Ehde DM, Robinsin LR (2001) Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain. Pain 91(3):317–322
Acknowledgments
We thank the generous support of the Bratty Family Fund, Michael and Karyn Goldstein Cancer Research Fund, Joey and Mary Furfari Cancer Research Fund, Pulenzas Cancer Research Fund, Joseph and Silvana Melara Cancer Research Fund, and Ofelia Cancer Research Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Appendices
Appendix 1 Daily diary questionnaire
Appendix 2
Rights and permissions
About this article
Cite this article
Chiu, N., Zhang, L., Gallo-Hershberg, D. et al. Which pain intensity scale from the Brief Pain Inventory correlates most highly with functional interference scores in patients experiencing taxane-induced arthralgia and myalgia?. Support Care Cancer 24, 2979–2988 (2016). https://doi.org/10.1007/s00520-016-3106-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3106-5